Sandy Spring Bank’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Sandy Spring Bank’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-7,650	Closed	-$1K	–	816
2018 Q4	$1K	Sell	7,650 -52,695	-87%	-$34.6K	﹤0.01%	765
2018 Q3	$103K	Hold	60,345	–	–	0.01%	373
2018 Q2	$105K	Buy	60,345 +7,362	+14%	+$12.7K	0.01%	380
2018 Q1	$97K	Buy	52,983 +3,960	+8%	+$8.36K	0.01%	376
2017 Q4	$109K	Buy	+49,023	New	+$122K	0.01%	341

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Sandy Spring Bank's SGYP Position: Q1 2019 in Review

Sandy Spring Bank sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 7,650 shares — an estimated $1K sold.

Sandy Spring Bank first reported a position in SGYP in Q4 2017 and held it in 5 quarters. The position peaked at $109K in Q4 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

Sandy Spring Bank reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
Sandy Spring Bank sold 7,650 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $1K.
Sandy Spring Bank first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2017 and held it in 5 quarters.
Sandy Spring Bank's Synergy Pharmaceuticals, Inc Common Stock position peaked at $109K in Q4 2017.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Sandy Spring Bank's 13F filing for Q1 2019, filed 6 May 2019.